Latest Breaking News On - New drug application - Page 9 : comparemela.com

Innovent:Phase 3 Trial Of Picankibart In Severe Plaque Psoriasis Meets Primary & Key Secondary Goals

Innovent:Phase 3 Trial Of Picankibart In Severe Plaque Psoriasis Meets Primary & Key Secondary Goals
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Instaforex companyInnovent biologics incNational medical products administrationInnovent biologicsNew drug applicationDrug evaluation

Genovate Announces Plans to Submit a New Drug Application for PMR to the U S Food & Drug Administration in the Second Half of 2025

/PRNewswire/ Genovate Biotechnology Co., Ltd. (TPEx: 4130), a Taiwan-based specialty pharmaceutical company, today announced its plans to submit a New Drug.

United statesT ai peiChia chen chuDrug administrationGenovate biotechnology co ltdPrnewswire genovate biotechnology co ltdNew drug applicationUnited states foodIntermittent claudicationGeneral managerCilostazol extended release tablets

Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis

Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew jerseyUnited statesBryan dunnMandy faheyJames chalmersEleanor barisserMartina flammerEsteve pharmaceuticalsPrnewswire insmed incorporated nasdaqCompany annual report on formCorporate communicationsSchool of medicineInsmed incorporatedExchange commissionDrug administration

Insmed Incorporated: Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis

-Phase 3 Study Achieves Primary Endpoint for Both Dosage Strengths of Brensocatib with Statistically Significant and Clinically Meaningful Reduction in Frequency of Pulmonary Exacerbations Versus

United kingdomNew jerseyUnited statesMartina flammerEleanor barisserJames chalmersMandy faheyBryan dunnEsteve pharmaceuticalsPrnewswire insmed incorporated nasdaqCompany annual report on formCorporate communicationsSchool of medicineInsmed incorporatedExchange commissionDrug administration

Shield Therapeutics files for South Korean regulatory approval for Accrufer

Shield Therapeutics files for South Korean regulatory approval for Accrufer
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited kingdomGreg madisonMinistry of foodShield therapeuticsKorea pharmaNew drug application